Applied Therapeutics, Inc.
NASDAQ:APLT
8 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.144 | 0.19 | -0.667 | 0 | 0 | 10.66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.122 | 0.119 | 0.347 | 0.118 | 0.115 | 0.114 | 0.113 | 0.111 | 0.109 | 0.108 | 0.107 | 0.104 | 0.104 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.022 | 0.071 | -1.014 | -0.118 | -0.115 | 10.546 | -0.113 | -0.111 | -0.109 | -0.108 | -0.107 | -0.104 | -0.104 | -0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.153 | 0.374 | 1.52 | 0 | 0 | 0.989 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 10.004 | 0.19 | 15.303 | 10.785 | 11.883 | 15.935 | 12.092 | 13.116 | 15.396 | 15.03 | 15.724 | 17.597 | 14.802 | 14.448 | 13.814 | 19.945 | 20.758 | 7.271 | 13.768 | 7.453 | 4.254 | 6.874 | 5.36 | 2.726 | 1.937 | 1.448 |
| General & Administrative Expenses
| 10.58 | 9.066 | 5.038 | 4.71 | 5.293 | 5.583 | 6.88 | 6.24 | 6.125 | 8.071 | 11.39 | 10.833 | 11.073 | 9.751 | 9.933 | 10.02 | 7.521 | 5.196 | 3.901 | 3.294 | 4.183 | 1.855 | 0.629 | 0.598 | 0.4 | 0.42 |
| Selling & Marketing Expenses
| -0.122 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.458 | 9.066 | 5.038 | 4.71 | 5.293 | 5.583 | 6.88 | 6.24 | 6.125 | 8.071 | 11.39 | 10.833 | 11.073 | 9.751 | 9.933 | 10.02 | 7.521 | 5.196 | 3.901 | 3.294 | 4.183 | 1.855 | 0.629 | 0.598 | 0.4 | 0.42 |
| Other Expenses
| -0.034 | -0.026 | -0.061 | 0.01 | -0.005 | 0.031 | 0.017 | -0.008 | -0.09 | -0.096 | -0.279 | -0.064 | -0.122 | -0.056 | -0.065 | -0.01 | 0.038 | -0.024 | 0 | 0 | 0 | 0 | -0.267 | -0.373 | -0.315 | -0.186 |
| Operating Expenses
| 20.462 | 9.256 | 20.341 | 15.495 | 17.176 | 21.518 | 18.972 | 19.356 | 21.521 | 23.101 | 27.114 | 28.43 | 25.875 | 24.199 | 23.747 | 29.965 | 28.279 | 12.467 | 17.669 | 10.747 | 8.437 | 8.729 | 5.989 | 3.324 | 2.337 | 1.868 |
| Operating Income
| -20.44 | -21.093 | -21.008 | -15.495 | -17.176 | -10.858 | -18.972 | -19.356 | -21.521 | -23.101 | -27.114 | -28.43 | -25.875 | -24.199 | -23.748 | -29.965 | -28.28 | -12.467 | -17.669 | -10.747 | -8.437 | -8.729 | -5.989 | -3.324 | -2.337 | -1.868 |
| Operating Income Ratio
| -141.944 | -111.016 | 31.496 | 0 | 0 | -1.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 23.338 | -62.845 | -17.023 | -26.875 | -12.809 | 0.721 | 4.543 | 0.255 | -4.336 | -0.02 | -0.279 | -0.064 | -0.122 | -0.056 | -0.065 | -0.01 | 0.038 | -0.024 | 0.036 | 0.034 | -0.6 | -0.001 | -0.488 | -0.373 | -0.315 | -0.186 |
| Income Before Tax
| 2.898 | -83.938 | -37.679 | -42.37 | -29.577 | -10.137 | -14.429 | -19.101 | -25.857 | -23.121 | -27.159 | -28.418 | -25.828 | -24.179 | -23.688 | -29.844 | -28.058 | -12.369 | -17.633 | -10.713 | -8.437 | -8.73 | -6.719 | -4.281 | -3.185 | -2.335 |
| Income Before Tax Ratio
| 20.125 | -441.779 | 56.49 | 0 | 0 | -0.951 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.119 | -11.557 | -0.118 | 12.396 | -0.721 | -8.611 | -0.291 | 8.473 | -0.056 | -0.51 | -0.076 | -0.169 | -0.076 | -0.001 | -0.131 | -0.182 | -0.122 | -0.046 | -10.747 | 0 | -8.729 | -5.747 | -2.74 | -1.804 | -1.587 |
| Net Income
| 2.898 | -83.938 | -37.679 | -42.37 | -29.577 | -9.416 | -5.818 | -18.81 | -34.33 | -23.065 | -27.159 | -28.418 | -25.828 | -24.179 | -23.689 | -29.844 | -28.059 | -12.369 | -17.633 | -10.713 | -8.437 | -8.73 | -6.719 | -4.281 | -3.185 | -2.335 |
| Net Income Ratio
| 20.125 | -441.779 | 56.49 | 0 | 0 | -0.883 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.02 | -0.67 | -0.45 | -0.47 | -0.37 | -0.17 | -0.12 | -0.39 | -1.28 | -0.88 | -1.05 | -1.09 | -0.99 | -1 | -0.98 | -1.33 | -1.27 | -0.59 | -0.85 | -0.63 | -0.6 | -0.51 | -0.39 | -0.47 | -0.35 | -0.25 |
| EPS Diluted
| -0.13 | -0.67 | -0.45 | -0.47 | -0.37 | -0.17 | -0.12 | -0.39 | -1.28 | -0.88 | -1.04 | -1.09 | -0.99 | -1 | -0.98 | -1.33 | -1.27 | -0.59 | -0.85 | -0.63 | -0.6 | -0.51 | -0.39 | -0.47 | -0.35 | -0.25 |
| EBITDA
| -20.318 | -21.093 | -4.04 | -15.495 | -4.256 | -11.327 | -23.113 | -19.28 | -17.164 | -22.993 | -27.007 | -28.326 | -25.771 | -24.099 | -23.648 | -29.87 | -28.186 | -12.374 | -17.669 | -10.747 | -8.437 | -8.729 | -5.989 | -3.324 | -2.337 | -1.868 |
| EBITDA Ratio
| -141.097 | -111.016 | 6.057 | 0 | 0 | -1.063 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |